EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - Analyst Ratings

eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of May 21, 2026, EXOZ trades at $9.40 with a market cap of $80.97M and a P/E ratio of -8.83. EXOZ moved -2.11% today. Year to date, EXOZ is -15.50%; over the trailing twelve months it is -10.22%. Its 52-week range spans $7.08 to $23.99. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate EXOZ?

The average price target is $0.00.

EXOZ Key Metrics

Key financial metrics for EXOZ
MetricValue
Price$9.40
Market Cap$80.97M
P/E Ratio-8.83
EPS$-1.09
Dividend Yield0.00%
52-Week High$23.99
52-Week Low$7.08
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-9.16M
Gross Margin0.00%

EXOZ Analyst Consensus

EXOZ analyst coverage data. Average price target: $0.00.

Latest EXOZ News

Recent EXOZ Insider Trades

  • Korman Tyler Paz sold 750 (~$7.89K) on Apr 9, 2026.
  • Korman Tyler Paz sold 750 (~$7.53K) on Apr 8, 2026.
  • Heltzen Michael bought 1.04K (~$10.63K) on Jul 2, 2025.

Common questions about EXOZ

What do analysts rate EXOZ?
The average price target is $0.00.
Does Rallies show EXOZ price targets?
Yes. Rallies tracks EXOZ analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is EXOZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.
EXOZ

EXOZ